Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Actinium Pharmaceuticals (ATNM) FCF Margin (2021 - 2022)

Actinium Pharmaceuticals (ATNM) has disclosed FCF Margin for 2 consecutive years, with 12862.22% as the latest value for Q3 2022.

  • Quarterly FCF Margin fell 1043475.0% to 12862.22% in Q3 2022 from the year-ago period, while the trailing twelve-month figure was 5473.33% through Dec 2025, changed N/A year-over-year, with the annual reading at 27426.67% for FY2025, N/A changed from the prior year.
  • FCF Margin for Q3 2022 was 12862.22% at Actinium Pharmaceuticals, down from 61440.0% in the prior quarter.
  • The five-year high for FCF Margin was 61440.0% in Q2 2022, with the low at 21965.22% in Q4 2021.